By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Febit today announced it is restructuring its business "as a consequence of its strategic focus on blood-based microRNA biomarker discovery."

As a result, CEO and President Cord Staehler has resigned and joined Siemens Healthcare. Hartmut Voss has joined the company as co-CEO. Jochen Kohlhaas is the other co-CEO and will continue as the company's chief financial officer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.